Filing Details

Accession Number:
0001567619-18-008315
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-18 19:58:29
Reporting Period:
2018-12-14
Accepted Time:
2018-12-18 19:58:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221590 Jacques Jean Bienaime C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-11-19 160 $0.00 182,041 No 5 G Indirect Shares held by Jean-Jacques Bienaime Family Trust
Common Stock Disposition 2018-11-20 540 $0.00 181,501 No 5 G Indirect Shares held by Jean-Jacques Bienaime Family Trust
Common Stock Acquisiton 2018-12-14 2,000 $17.86 290,290 No 4 M Direct
Common Stock Disposition 2018-12-14 2,000 $92.64 288,290 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect Shares held by Jean-Jacques Bienaime Family Trust
No 5 G Indirect Shares held by Jean-Jacques Bienaime Family Trust
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy Common Stock) Disposition 2018-12-14 2,000 $0.00 2,000 $17.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-06-17 2018-12-16 No 4 M Direct
Footnotes
  1. On November 19, 2018, the reporting entity gifted 160 shares to an educational institution.
  2. On November 20, 2018, the reporting entity gifted 540 shares to a non-profit organization.
  3. Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.
  4. Reflects the number of options outstanding after the transactions from this specific stock option grant.